Seborrheic Dermatitis Clinical Trial
Official title:
Avaliação da eficácia de um Produto de Uso tópico Contendo Hidrocortisona no Tratamento de Dermatite seborréica na Face.
Clinical single-blind randomized comparison with the overall objective of evaluating the
clinical efficacy of the products Nutracort lotion and Nutracort cream in the treatment of
seborrheic dermatitis on the face.
Will be held clinical and perceived efficacy assessment and instrumental measurements. Each
product will be applied at half face for 7 consecutive days and all applications will be
monitored in the research site. 60 volunteers will be recruited.
Evaluations will be held at the following times: T0 - before the initial application of the
product; T1 - 24 hours after starting treatment, T2 - 48 hours after starting treatment, T3
- 72 hours after initiation of treatment, T4 - 96 hours after the start treatment, T7 - 7
days after initiation of treatment.
n/a
Observational Model: Case-Only, Time Perspective: Prospective
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01703793 -
Safety and Efficacy Study in Subjects With Seborrheic Dermatitis
|
Phase 2 | |
| Completed |
NCT01203189 -
Seborrheic Dermatitis: Ketoconazole 2% Foam Versus Ketoconazole 2% Shampoo
|
N/A | |
| Completed |
NCT00991198 -
The Role of Topically Dissolved Oxygen (TDO) to Ameliorate Signs of Photodamage
|
Phase 2 | |
| Completed |
NCT03567980 -
A Proof of Concept Clinical Trial Evaluating the Safety and Efficacy of Eucrisa (Crisaborole) in Patients With Seborrheic Dermatitis
|
Phase 4 | |
| Recruiting |
NCT03688971 -
Omiganan Twice a Day (BID) in Patients With Facial Seborrheic Dermatitis
|
Phase 2 | |
| Recruiting |
NCT01139749 -
Efficacy and Safety of Low-dose Oral Isotretinoin for Seborrhea
|
Phase 4 | |
| Completed |
NCT05105139 -
Study to Evaluate the Safety of Sebryl® and Sebryl Plus® in Seborrheic Dermatitis and Psoriasis of Scalp
|
||
| Completed |
NCT01591070 -
Proactive Treatment of Tacrolimus Ointment for Adult Facial Seborrheic Dermatitis
|
Phase 4 | |
| Completed |
NCT05787860 -
Ruxolitinib in Seborrheic Dermatitis
|
Phase 2 | |
| Completed |
NCT00403559 -
A 4 Week Study of Elidel (Pimecrolimus) for the Treatment of Seborrheic Dermatitis
|
Phase 2 | |
| Not yet recruiting |
NCT00767546 -
Botulinum Toxin for Treatment of Seborrhic Dermatitis in Parkinsonian Patients
|
Phase 1 | |
| Terminated |
NCT01315951 -
Petrolatum's Effect on Initial Symptoms of Nonscalp Seborrheic Dermatitis and Preventing Exacerbation
|
N/A | |
| Recruiting |
NCT05942248 -
The Use of Image-Based Computer Gradings in the Analysis of Acne, Rosacea, Melasma, and Seborrheic Dermatitis
|
N/A | |
| Recruiting |
NCT06013371 -
PDE4 Inhibition in Seborrheic Dermatitis and Papulopustular Rosacea
|
Phase 2 | |
| Recruiting |
NCT05319444 -
Cleansing Device for the Treatment of Scalp and Hair Conditions
|
N/A | |
| Completed |
NCT04445987 -
Long-Term Safety of ARQ-154 Foam in Subjects With Seborrheic Dermatitis
|
Phase 2 | |
| Completed |
NCT04973228 -
Trial of PDE4 Inhibition With Roflumilast (ARQ-154) Foam 0.3% for the Management of Seborrheic Dermatitis (STRATUM)
|
Phase 3 | |
| Completed |
NCT03114111 -
Pilot Study for the Use of Photodynamic Therapy in the Treatment of Seborrheic Dermatitis
|
Early Phase 1 | |
| Completed |
NCT02656368 -
Safety and Efficacy of SEBORRHEAMEDIS Face Cream in Patients With Seborrheic Dermatitis
|
N/A | |
| Completed |
NCT00830908 -
HairMax LaserComb Open Label Study to Treat Seborrheic Dermatitis
|
N/A |